Macrophage-derived lymphatic endothelial cell progenitors (M-LECP) are a population of VEGFR3/FLT4/CD310/bone marrow-derived myeloid precursors that contribute to tumor lymphangiogenesis, metastases, and resistance to chemotherapy through activation of TLR receptors. The gene discussed is FLT4; the disease is neoplasm.